Editorial: does TAF have a better or worse safety profile than TDF , to treat hepatitis B? Authors' reply / Y. Lim, P. Lampertico. - In: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. - ISSN 0269-2813. - 55:8(2022 Apr), pp. 1044-1045. [10.1111/apt.16886]
Editorial: does TAF have a better or worse safety profile than TDF , to treat hepatitis B? Authors' reply
P. LamperticoUltimo
2022
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Aliment Pharmacol Ther - 2022 - Lim - Editorial does TAF have a better or worse safety profile than TDF to treat.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
177.59 kB
Formato
Adobe PDF
|
177.59 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
